Show simple item record

dc.contributor.authorChitneniID, Pooja
dc.contributor.authorBwana, Mwebesa Bosco
dc.contributor.authorMuyindike, Winnie
dc.contributor.authorOwembabazi, Moran
dc.contributor.authorKalyebara, Paul Kato
dc.contributor.authorByamukama, Adolf
dc.contributor.authorMbalibulha, Yona
dc.contributor.authorSmith, Patricia M.
dc.contributor.author. Hsu, Katherine K
dc.contributor.author. Haberer, Jessica E
dc.contributor.authorKaida, Angela
dc.contributor.authorMatthews, Lynn T.
dc.date.accessioned2022-01-13T07:58:42Z
dc.date.available2022-01-13T07:58:42Z
dc.date.issued2020-07-27
dc.identifier.citationChitneni P, Bwana MB, Muyindike W, Owembabazi M, Kalyebara PK, Byamukama A, et al. (2021) STI prevalence among men living with HIV engaged in safer conception care in rural, southwestern Uganda. PLoS ONE 16(3): e0246629. https://doi.org/10.1371/journal. pone.0246629en_US
dc.identifier.urihttp://ir.must.ac.ug/xmlui/handle/123456789/1138
dc.description.abstractHIV care provides an opportunity to integrate comprehensive sexual and reproductive healthcare, including sexually transmitted infection (STI) management. We describe STI prevalence and correlates among men living with HIV (MLWH) accessing safer conception care to conceive a child with an HIV-uninfected partner while minimizing HIV transmission risks. This study reflects an ongoing safer conception program embedded within a regional referral hospital HIV clinic in southwestern Uganda. We enrolled MLWH, planning for pregnancy with an HIV-uninfected partner and accessing safer conception care. Participants completed interviewer-administered questionnaires detailing socio-demographics, gender dynamics, and sexual history. Participants also completed STI laboratory screening for syphilis (immunochromatographic testing confirmed by rapid plasma regain), and chlamydia, gonorrhea, trichomonas’s, and HIV-RNA via Gene pert nucleic acid amplification testing. Invariable associations of STI covariates were assessed using Fisher’s exact test. Among the 50 men who completed STI screening, median age was 33 (IQR 31–37) years, 13/50 (26%) had �2 sexual partners in the prior three months, and 46/50 (92%) had HIVRNA <400 copies/mill Overall, 11/50 (22%) had STIs: 16% active syphilis, 6% chlamydia. All participants initiated STI treatment. STI prevalence was associated with the use of threats/intimidation to coerce partners into sex (27% vs 3%; p = 0.03), although absolute numbers were small. We describe a 22% curable STI prevalence among a priority population at higher risk for transmission to partners and neonates. STI screening and treatmenten_US
dc.description.sponsorshipGrand Challenges Canadaen_US
dc.language.isoen_USen_US
dc.publisherPLOS ONEen_US
dc.subjectSTI prevalenceen_US
dc.subjectmen living withen_US
dc.subjectHIVen_US
dc.subjectengageden_US
dc.subjectsafer conceptionen_US
dc.subjectruralen_US
dc.titleSTI prevalence among men living with HIV engaged in safer conception care in rural, southwestern Ugandaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

  • Research Articles [432]
    These are different research articles about different Scholars

Show simple item record